In the context of 2019 coronavirus disease (COVID-19), considerable attention has been paid to mathematical models for predicting country- or region-specific future pandemic developments. In this work, we developed an SVICDR model that includes a susceptible, an all-or-nothing vaccinated, an infected, an intensive care, a deceased, and a recovered compartment. It is based on the susceptible-infectious-recovered (SIR) model of Kermack and McKendrick, which is based on ordinary differential equations (ODEs).
View Article and Find Full Text PDFIn this paper, we attempt to set a framework of conditions for model-specific predictions of newly arising TB epidemics by e.g. immigration of infected persons from high prevalence countries.
View Article and Find Full Text PDFBecause most HIV-infected patients die of diseases caused by opportunistic pathogens, the prevention of these infections is an important clinical issue. Cost-containment in the healthcare system is a subject of high priority in public debate. Methods to determine cost-effectiveness of different therapeutic strategies are therefore needed to obtain valid data as the basis for decisions on cost reduction without a decrease in the quality of care.
View Article and Find Full Text PDFThe prevailing uncertainty about the pharmacoeconomic positioning of granulocyte colony-stimulating factor (G-CSF) in the prevention and treatment of chemotherapy-induced febrile neutropenia has resulted in a number of pharmacoeconomic evaluations published in the past 10 years. These studies vary considerably regarding the approaches used and the results presented. In order to contribute to a clearer pharmacoeconomic positioning of G-CSF, a systematic review of economic evaluations was carried out.
View Article and Find Full Text PDF